Johannes Gutenberg-Universität Mainz
- 6131/39-0
D'Ancona, Giuseppe; Ince, Huseyin; Schillinger, Wolfgang et al.
Percutaneous treatment of mitral regurgitation in patients with impaired ventricular function: Impact of intracardiac electronic devices (from the German Transcatheter Mitral Valve Interventions Registry)CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS. Bd. 94. H. 5. 2019 S. 755-763
Linecker, Michael; Kuemmerli, Christoph; Kambakamba, Patryk et al.
Performance validation of the ALPPS risk modelHPB. Bd. 21. H. 6. 2019 S. 711-721
Mergens, Manuel
Performancemessung von LebenszyklusfondsWiesbaden: Springer Fachmedien Wiesbaden GmbH ; Springer Gabler 2019 0 S. (Research)
Messias, Ana; Rocha, Salomao; Wagner, Wilfried et al.
Peri-implant marginal bone loss reduction with platform-switching components: 5-Year post-loading results of an equivalence randomized clinical trialJOURNAL OF CLINICAL PERIODONTOLOGY. Bd. 46. H. 6. 2019 S. 678-687
Kette, Alexandra; Pausch, Tobias; Wagner, Wilfried et al.
Periimplant defect grafting with autogenous bone or bone graft material in immediate implants placement in molar extraction sites First results of a prospective randomized studyIMPLANTOLOGIE. Bd. 27. H. 3. 2019 S. 233-248
Straub, Beate K.; Witzel, Hagen R.; Pawella, Lena M. et al.
Perilipin 1 Expression Differentiates Liposarcoma from Other Types of Soft Tissue SarcomaAMERICAN JOURNAL OF PATHOLOGY. Bd. 189. H. 8. 2019 S. 1547-1558
Kozuschek, Sandra Martina
Periodische Strukturen im invarianten Maß von stochastischen Hodgkin-Huxley-ProzessenMainz: Univ. 2019 91 S.
Dietlein, Thomas S.; Erb, Carl; Hoffmann, Esther
Perioperative Anti-inflammatory Treatment in Glaucoma SurgeryKLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE. Bd. 236. H. 5. 2019 S. 647-652
Al-Batran, Salah-Eddin; Homann, Nils; Pauligk, Claudia et al.
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trialLANCET. Bd. 393. H. 10184. 2019 S. 1948-1957